“The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global blood disorders market. The report analyzes the markets for blood ... Read more
"Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability", which provides in-depth analysis of epilepsy market within the Asia-Pacific (APAC) market covering the four countries of Australia, China, India and Japan. The report provides an estimation of ... Read more
Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape. The current Hepatitis C treatment landscape consists of a combination of pegylated interferon, ribavirin and, in patients infected with genotype 1 hepatitis C, one of two direct- ... Read more
Stem cell technology is set to play a significant role in the pharmaceutical industry of the future. The opportunities for using stem cells across drug discovery, disease research, drug development and treatments are wide-ranging, yet largely unproven at present.
Even if companies are not interested in joining the first wave of stem cell therapy developers, they need to be monitoring this sector in order to understand future competitive threats. ... Read more
The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential. Externalization strategies are a key means to boost future revenues and, indeed more imminently, to satisfy shareholder demands. However, the increasing size of the leading biopharmaceutical companies is necessitating their involvement in growing the numbers and size of deals year by ... Read more
The global intrauterine contraceptive devices market is estimated to grow at a CAGR of 6.8% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of Affordable Care Act (ACA), ... Read more
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the US. It identifies key ... Read more
The endometrial cancer is one of the most common forms of cancer women suffer from these days. As the condition is being diagnosed for females all over the world, there has been certain updates in its healthcare cost, facilities, technologies, treatments, and other characteristics. The “Endometrial Cancer-Pipeline Review, H2 2015” market research reports give an overview about all the aspects of it. The information contributes ... Read more
The endometrial cancer is one of the most common forms of cancer women suffer from these days. As the condition is being diagnosed for females all over the world, there has been certain updates in its healthcare cost, facilities, technologies, treatments, and other characteristics. The “Endometrial Cancer-Pipeline Review, H2 2015” market research reports give an overview about all the aspects of it. The information contributes ... Read more
July 7, 2017: Aarkstore Announces the Publication of its Research Report “Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2017”
Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2017, provides an overview of the Vancomycin-Resistant Stap
Global Markets Directs latest Pharmaceutical and Healthcare ... Read more
